THRD News

Thread Bancorp, Inc. Welcomes Dan Chang as New General Counsel and Chief Compliance Officer, Supporting Expansion of Embedded Banking Services

THRD

(NASDAQ:THRD) NASHVILLE, Tenn.--(BUSINESS WIRE)--Thread Bancorp, Inc. (“Thread” or the “Company”), the parent company of Thread Bank (the “Bank”), today announced the appointment of Dan Chang as General Counsel and Chief Compliance Officer. Chang will lead regulatory and compliance oversight, overseeing the Bank’s continued commitment to regulatory soundness as it broadens the range of consumer and commercial services offered through its embedded banking platform. Chang joins Thread from Splash Financial, In

September 4, 2025Management
Read more →

Thread Bancorp, Inc. Welcomes Marty Miracle as Chief Digital Officer to Drive Scalable, Compliant Embedded Banking Innovation

THRD

NASHVILLE, Tenn.--(BUSINESS WIRE)--Thread Bancorp, Inc. and Thread Bank (together, “Thread”) today announced the appointment of Marty Miracle as Chief Digital Officer, further reinforcing Thread’s commitment to digital transformation and technology-driven growth. In this executive role, Miracle will lead the development and execution of Thread’s digital strategy, building on its strong foundation of embedded, business, and personal banking solutions. Miracle joins Thread from Sutton Bank, where

Third Harmonic Bio Announces Stockholder Approval Of Liquidation And Dissolution Plan With Initial Distribution Expected In The Range Of $5.30-$5.35; Co. Initiates Sale Process Of THB335

THRD

June 12, 2025
Read more →

Third Harmonic Bio Q1 EPS $(0.35) Misses $(0.29) Estimate

THRD

May 8, 2025
Read more →

Third Harmonic Bio Stock Is Up 40% Monday: What's Happening?

THRD

Third Harmonic Bio Inc (NASDAQ:THRD) shares are soaring on Monday after the company announced a plan of liquidation and dissolution.

April 14, 2025
Read more →

Third Harmonic Bio Announces Plan Of Dissolution With Payout Between $246.6M–$255.4M Pending Stockholder Approval

THRD

April 14, 2025
Read more →

Stifel Downgrades Third Harmonic Bio to Hold, Lowers Price Target to $5

THRD

March 28, 2025
Read more →

Third Harmonic Bio FY 2024 GAAP EPS $(1.09) Beats $(1.18) Estimate

THRD

March 27, 2025
Read more →

Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape

THRD

Third Harmonic Bio plans a Phase 2 trial for THB335 in chronic spontaneous urticaria and will reduce its workforce by 50% while reviewing strategic options.

February 12, 2025
Read more →

Third Harmonic Bio, Inc. IPOs Tomorrow, Here's What You Need To Know

THRD

Third Harmonic Bio, Inc. (NASDAQ:THRD) IPO will take place September, 15 on the NASDAQ exchange under the ticker THRD. The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 14, 2023.

September 14, 2022
Read more →